Affine Formulations Limited - Company Profile

It is a pharma public limited company based in Indore, Madhya Pradesh, India, established in 2006.
2006 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Affine Formulations Limited

Affine Formulations Limited, a active public limited company, was established on 04 July 2006 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP2006PLC018755. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.00 Cr.

Formerly known as Affine Formulations Private Limited. It upholds a compliant status. Employing 26 professional, Its leadership includes Shailendra Biyani (Director), Pradhyumn Nyati (Director), Vijay Kumar Nyati (Director). Past directors included Mahesh Jakhatia, Pavitra Jhanjhari, Manish Nyati. It holds ₹13.39 Cr open charges and ₹8.81 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 28/10 Talwali Dewas Naka, Indore, Madhya Pradesh, 452010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP2006PLC018755

  • Registration Number

    018755

  • Incorporation Date

    04 July 2006

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹6.00 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 6.00 Cr
  • Company Age 19 Year, 8 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 13.39 Cr
  • Satisfied Charges ₹ 8.81 Cr
  • Revenue Growth **** 4.50%
  • Profit Growth **** -28.48%
  • Ebitda **** 0.72%
  • Net Worth 4.13%
  • Total Assets -15.74%
Company report

Affine Formulations Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Affine Formulations Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Affine Formulations Limited?
Current Directors
Name Designation Appointment Date Status
Shailendra Biyani Director 15 Apr 2008 Current
Pradhyumn Nyati Director 15 Apr 2008 Current
Vijay Kumar Nyati Director 04 Jul 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Additional Director 05 Sep 2016 Past
Pramod Abcsdd Additional Director 05 Sep 2016 Past
Pramod Abcsdd Director 16 Apr 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Affine Formulations.

Affine Formulations Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.5% increase. The company also saw a substantial fall in profitability, with a 28.48% decrease in profit. The company's net worth moved up by a moderate rise of 4.13%.

Affine Formulations revenue growth over time
Affine Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.50%
*******
*******
*******
*******
Revenue from Operations
*******
 4.68%
*******
*******
*******
*******
Total Assets
*******
 -15.74%
*******
*******
*******
*******
Profit or Loss
*******
 -28.48%
*******
*******
*******
*******
Net Worth
*******
 4.13%
*******
*******
*******
*******
EBITDA
*******
 0.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Affine Formulations?

In 2022, Affine Formulations had a promoter holding of 32.43% and a public holding of 67.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹133,900,000.00

Satisfied Charges

₹88,100,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 13.39 Cr
Latest Charge Details
Date Lender Amount Status
26 Sep 2018 Axis Bank Limited ₹13.39 Cr Open
07 Dec 2006 State Bank Of India ₹8.81 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Affine Formulations?

Affine Formulations has a workforce of 26 employees as of Feb 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Affine Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Affine Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Affine Formulations
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Affine Formulations Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    Affine Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Gwalior. was recorded as a recent event.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 13.39 Cr registered on 26 Sep 2018 with Charge ID 100219357 was modified on 08 Feb 2022. was completed.

  • Charges

    The activity A charge registered on 07 Dec 2006 via Charge ID 10033474 with State Bank Of India was fully satisfied on 18 Jan 2019. was completed.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 13.39 Cr with Charge ID 100219357 was registered on 26 Sep 2018. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 8.81 Cr registered on 07 Dec 2006 with Charge ID 10033474 was modified on 07 Apr 2012. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Affine Formulations Limited?

The CIN of Affine Formulations Limited is U24232MP2006PLC018755.

Where is Affine Formulations Limited headquartered?

Affine Formulations Limited is headquartered at 28/10 Talwali Dewas Naka, Indore, Madhya Pradesh, 452010.

When was Affine Formulations Limited incorporated?

Affine Formulations Limited was incorporated on 04 July 2006.

Who are the current directors of Affine Formulations Limited?

The current directors of Affine Formulations Limited are

What is the primary industry of Affine Formulations Limited?

The primary industry of Affine Formulations Limited is Manufacturing.

Is Affine Formulations Limited a listed company?

Affine Formulations Limited is unlisted.

What is the capital structure of Affine Formulations Limited?

The authorized capital of Affine Formulations Limited is ₹10.00 Cr, and the paid-up capital is ₹6.00 Cr.

What is the compliance status of Affine Formulations Limited?

The compliance status of Affine Formulations Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available